GALR1 activators are chemical compounds that enhance the activity of the G-protein-coupled receptor GALR1, also known as Galanin Receptor 1. GALR1 is part of a family of receptors that respond to the neuropeptide galanin, which is involved in a variety of physiological processes in the central and peripheral nervous systems. Activators of GALR1 can operate through direct interaction with the receptor, mimicking the natural ligand's effect to stimulate the receptor or by stabilizing the receptor in its active conformation. Indirect activators may increase the expression of GALR1 on the cell surface or modulate the receptor's activity through interaction with other signaling molecules or pathways that influence GALR1.
The activation of GALR1 by these compounds leads to the initiation of intracellular signaling cascades involving the exchange of guanosine diphosphate for guanosine triphosphate on the G-protein, followed by the dissociation of the G-protein into its alpha and beta-gamma subunits. These subunits then interact with various downstream effectors, such as adenylate cyclase, phospholipase C, or ion channels, to exert their cellular effects. Understanding the activation mechanism of GALR1 by these activators provides important insights into the intricate signaling pathways modulated by galanin and its receptors and contributes to the fundamental knowledge of neurochemical communication.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylate cyclase, increasing cAMP levels. High cAMP levels can lead to increased activity of GALR1. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a non-specific phosphodiesterase inhibitor. By inhibiting phosphodiesterase, IBMX increases cAMP levels, which can stimulate GALR1 activity. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram is a specific PDE4 inhibitor. It increases cAMP levels, potentially stimulating GALR1 activity. | ||||||
SQ 22536 | 17318-31-9 | sc-201572 sc-201572A | 5 mg 25 mg | $95.00 $363.00 | 13 | |
SQ 22536 is an adenylate cyclase inhibitor. It decreases cAMP production, potentially leading to a compensatory increase in GALR1 activity. | ||||||
NKH 477 | 138605-00-2 | sc-204130 sc-204130A | 5 mg 50 mg | $223.00 $922.00 | 1 | |
NKH477 is an adenylate cyclase activator. It increases cAMP levels, potentially stimulating GALR1 activity. | ||||||
Zardaverine | 101975-10-4 | sc-201208 sc-201208A | 5 mg 25 mg | $88.00 $379.00 | 1 | |
Zardaverine is a PDE3 and PDE4 inhibitor. It increases cAMP levels, potentially stimulating GALR1 activity. | ||||||
Ro 20-1724 | 29925-17-5 | sc-200709 sc-200709A sc-200709B | 100 mg 1 g 5 g | $87.00 $426.00 $1574.00 | 17 | |
Ro 20-1724 is a PDE4 inhibitor. It increases cAMP levels, potentially stimulating GALR1 activity. | ||||||
Vardenafil | 224785-90-4 | sc-362054 sc-362054A sc-362054B | 100 mg 1 g 50 g | $526.00 $735.00 $16653.00 | 7 | |
Vardenafil is a PDE5 inhibitor. It increases cAMP levels, potentially stimulating GALR1 activity. | ||||||
Etazolate Hydrochloride | 35838-58-5 | sc-201186 sc-201186A | 5 mg 25 mg | $61.00 $255.00 | 5 | |
Etazolate is a PDE4 inhibitor. It increases cAMP levels, potentially stimulating GALR1 activity. | ||||||
Cilostamide (OPC 3689) | 68550-75-4 | sc-201180 sc-201180A | 5 mg 25 mg | $92.00 $357.00 | 16 | |
Cilostamide is a PDE3 inhibitor. It increases cAMP levels, potentially stimulating GALR1 activity. | ||||||